Marked TGF-β-regulated miRNA expression changes in both COPD and control lung fibroblasts.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 12 2019
Historique:
received: 11 03 2019
accepted: 14 11 2019
entrez: 5 12 2019
pubmed: 5 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

COPD is associated with disturbed tissue repair, possibly due to TGF-β-regulated miRNA changes in fibroblasts. Our aim was to identify TGF-β-regulated miRNAs and their differential regulation and expression in COPD compared to control fibroblasts. Small RNA sequencing was performed on TGF-β-stimulated and unstimulated lung fibroblasts from 15 COPD patients and 15 controls. Linear regression was used to identify TGF-β-regulated and COPD-associated miRNAs. Interaction analysis was performed to compare miRNAs that responded differently to TGF-β in COPD and control. Re-analysis of previously generated Ago2-IP data and Enrichr were used to identify presence and function of potential target genes in the miRNA-targetome of lung fibroblasts. In total, 46 TGF-β-regulated miRNAs were identified in COPD and 86 in control fibroblasts (FDR < 0.05). MiR-27a-5p was the most significantly upregulated miRNA. MiR-148b-3p, miR-589-5p and miR-376b-3p responded differently to TGF-β in COPD compared to control (FDR < 0.25). MiR-660-5p was significantly upregulated in COPD compared to control (FDR < 0.05). Several predicted targets of miR-27a-5p, miR-148b-3p and miR-660-5p were present in the miRNA-targetome, and were mainly involved in the regulation of gene transcription. In conclusion, altered TGF-β-induced miRNA regulation and differential expression of miR-660-5p in COPD fibroblasts, may represent one of the mechanisms underlying aberrant tissue repair and remodelling in COPD.

Identifiants

pubmed: 31796837
doi: 10.1038/s41598-019-54728-4
pii: 10.1038/s41598-019-54728-4
pmc: PMC6890791
doi:

Substances chimiques

Culture Media 0
MicroRNAs 0
Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18214

Références

PLoS One. 2017 Sep 14;12(9):e0183815
pubmed: 28910321
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1841-6
pubmed: 17264218
Circulation. 2017 Sep 5;136(10):927-939
pubmed: 28676520
PLoS One. 2016 Jun 30;11(6):e0157998
pubmed: 27362794
Swiss Med Wkly. 2009 Oct 3;139(39-40):554-63
pubmed: 19838873
J Biol Chem. 2016 Apr 15;291(16):8644-52
pubmed: 26769970
Am J Respir Crit Care Med. 2001 May;163(6):1476-83
pubmed: 11371421
Cell Res. 2015 Jul;25(7):837-50
pubmed: 26045162
Am J Respir Cell Mol Biol. 2010 May;42(5):626-32
pubmed: 19597127
Am J Pathol. 2018 Oct;188(10):2207-2222
pubmed: 30253845
J Thorac Dis. 2019 Jul;11(7):3055-3069
pubmed: 31463135
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
Am J Respir Crit Care Med. 2017 Jan 1;195(1):43-56
pubmed: 27409149
Annu Rev Pathol. 2009;4:435-59
pubmed: 18954287
COPD. 2005 Mar;2(1):17-25
pubmed: 17136957
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Cell Death Dis. 2014 Dec 11;5:e1564
pubmed: 25501825
Nucleic Acids Res. 2012 Jan;40(1):37-52
pubmed: 21911355
PLoS One. 2017 Sep 7;12(9):e0184039
pubmed: 28880936
Cell Physiol Biochem. 2018;50(3):1140-1153
pubmed: 30355907
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
In Vitro Cell Dev Biol Anim. 2015 Apr;51(4):390-9
pubmed: 25552310
Thorax. 2015 Jan;70(1):21-32
pubmed: 24990664
Exp Lung Res. 2003 Jul;29(5):291-302
pubmed: 12746043
J Allergy Clin Immunol. 2016 Jan;137(1):58-67
pubmed: 26148798
Biosci Rep. 2015 Jan 14;35(1):
pubmed: 25300915
Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S11-9
pubmed: 22209925
Eur Respir J. 2015 Sep;46(3):807-18
pubmed: 26250493
Am J Respir Crit Care Med. 2008 Aug 1;178(3):240-7
pubmed: 18511705
Avicenna J Med Biotechnol. 2010 Oct;2(4):161-79
pubmed: 23407304
Genome Biol. 2003;4(10):231
pubmed: 14519192
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Respir Res. 2004 Nov 30;5:24
pubmed: 15571627
J Lipid Res. 2015 Jan;56(1):38-50
pubmed: 25327529
Respir Res. 2008 Dec 16;9:83
pubmed: 19087346
Methods Mol Biol. 2013;971:265-76
pubmed: 23296969
Chest. 2017 Jul;152(1):58-69
pubmed: 28315337
Respir Med. 2009 Jul;103(7):1083-9
pubmed: 19186046
Int J Chron Obstruct Pulmon Dis. 2018 Aug 10;13:2387-2398
pubmed: 30127601
Thorax. 2015 Aug;70(8):782-91
pubmed: 25995155
Am J Respir Crit Care Med. 2008 Aug 1;178(3):248-60
pubmed: 18467512
Am J Physiol Lung Cell Mol Physiol. 2013 Oct 15;305(8):L582-9
pubmed: 23997174
Genes Dev. 1991 May;5(5):868-79
pubmed: 1851123
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

J Ong (J)

University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.
University of Groningen, University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

A Faiz (A)

University of Groningen, University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.
University of Groningen, University Medical Centre Groningen, Department of Pulmonary Diseases, Groningen, The Netherlands.
University of Technology Sydney, Respiratory Bioinformatics and Molecular Biology (RBMB) Faculty of Science, Ultimo, NSW, 2007, Australia.

W Timens (W)

University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.
University of Groningen, University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

M van den Berge (M)

University of Groningen, University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.
University of Groningen, University Medical Centre Groningen, Department of Pulmonary Diseases, Groningen, The Netherlands.

M M Terpstra (MM)

University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, The Netherlands.

K Kok (K)

University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, The Netherlands.

A van den Berg (A)

University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.

J Kluiver (J)

University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.

C A Brandsma (CA)

University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands. c.a.brandsma@umcg.nl.
University of Groningen, University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands. c.a.brandsma@umcg.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH